ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

Why Pembrolizumab is on this study

  • The record lists it as a treatment.
  • A model not recorded judged it tested: part of what the study tests. Nov 1, 2026, 6:41 AM UTC
  • The role rule says the same.
  • So Pembrolizumab's page lists this study under “Testing it”.
4 links0 made here, not in the record7 judgments2 judges (the rules as one: Rule based)1 record change seen
Model not recordedRule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06083844Phase II Investigation ofPembrolizumab inCombination WithBevacizumab and OralCyclophosphamide inPatients With High GradeOvarian Cancer andM.D. Anderson Cancer CenterPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 12 · ClinicalTrials.gov record · Version of 2026-11-12Version of 2026-11-12CONDITIONSOvarian NeoplasmsThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSPembrolizumabIntervention entry›Nov 1 · A model not recorded · TestedNov 18 · Rule based · TestedTestedBevacizumabIntervention entry›Nov 1 · A model not recorded · TestedNov 18 · Rule based · TestedTestedCyclophosphamideIntervention entry›Nov 1 · A model not recorded · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
1 version of the record seen on ClinicalTrials.gov, Nov 12 · changes seen, not judgments
Nov 1PembrolizumabA model not recordedTestedCurrent
Nov 1BevacizumabA model not recordedTestedCurrent
Nov 1CyclophosphamideA model not recordedTestedCurrent
Nov 18PembrolizumabRule based · role ruleTestedAgrees
Nov 18BevacizumabRule based · role ruleTestedAgrees
Nov 18CyclophosphamideRule based · role ruleTestedAgrees
As of nowOvarian NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.